QUOTED. 17 March 2021. Russ Johannesson.
Executive Summary
Glooko raised $30m in a series D and will use the proceeds to expand into new geographies, take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions and explore tuck-in acquisitions. See what Glooko’s CEO Russ Johannesson said about it here.
“Certainly, [we will expand our sales and marketing groups] with a heavy emphasis on the US market where there have been favorable changes in the reimbursement dynamics for providers, but that’s a trend that’s happening around the globe and we’re taking advantage of that.” – Russ Johannesson, CEO, Glooko
Click here for a free trial of Medtech Insight